Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × tinostamustine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1

Interventions

Cisplatin 21 Magnetic Resonance Spectroscopy 19 Carboplatin 17 pembrolizumab 15 Specimen Handling 15 Gemcitabine 11 Pemetrexed 10 Paclitaxel 10 Nivolumab 10 Doxorubicin 10 Bevacizumab 10 atezolizumab 9 Radiotherapy 8 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Radiation 7 Oxaliplatin 7 Docetaxel 7 Biopsy 7 Ipilimumab 6 Cyclophosphamide 6 venetoclax 5 Temozolomide 5 Rituximab 5 Radiotherapy, Intensity-Modulated 5 Immunoglobulin G 5 Etoposide 5 Drug Therapy 5 Disulfides 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03970447 2026-04-08

GBM AGILE

Global Coalition for Adaptive Research

Phase 2/3 Recruiting

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡